0001140361-14-042931.txt : 20141120
0001140361-14-042931.hdr.sgml : 20141120
20141120153201
ACCESSION NUMBER: 0001140361-14-042931
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141118
FILED AS OF DATE: 20141120
DATE AS OF CHANGE: 20141120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERLIHY WALTER C
CENTRAL INDEX KEY: 0001241029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 141238870
MAIL ADDRESS:
STREET 1: C/O REPLIGEN CORP 41
STREET 2: SEYON ST. BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc1.xml
FORM 4
X0306
4
2014-11-18
0
0000730272
REPLIGEN CORP
RGEN
0001241029
HERLIHY WALTER C
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
PRESIDENT, CEO
Common Stock
2014-11-18
4
S
0
47228
23.47
D
500819
D
Common Stock
2014-11-19
4
S
0
4158
22.95
D
496661
D
$23.47 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$22.95 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.89 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2014-11-20